Patent ID: 7714005

Claim:
A method of treating prostate cancer in a subject previously identified as having an unwanted cell proliferation of the prostate, the process comprising administering to the subject a therapeutically effective amount of at least one compound of the following formula II, formula III, formula VIII, formula IX or formula X: wherein X 1 is selected from H, alkyl, alkoxy, halo, nitro and combinations thereof, and X 2 is selected from H, alkyl, alkoxy, halo and combinations thereof, wherein X 1 is selected from H, alkyl, alkoxy, halo, nitro, haloalkylaryl, haloaryl, alkylaryl and combinations thereof, and X 2 is selected from H, methyl, methoxy, and bromo, wherein W is selected from O, S and combinations thereof; Y is selected from straight chain alkenyl, branched alkenyl and combinations thereof, and Z′ is H, wherein Y is selected from straight chain alkenyl, branched alkenyl and combinations thereof, wherein Y is selected from straight chain alkenyl, branched alkenyl and combinations thereof, and Z′ is H, and pharmaceutically acceptable salts thereof.